IQVIA Holdings Inc (IQV)

Exchange
NYSE
Symbol
IQV
Sector
Trade & Services
Industry
Services-commercial Physical & Biological Research
Description
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    191.81
  • High
    200.14
  • Low
    191.44
  • Close
    197.27
  • Volume
    3,346,310

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
4.23
Payables turnover
—
Working capital turnover
—
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
86.25
Number of days of payables
—
Fixed asset turnover
27.36
Total asset turnover
0.54
 Liquidity ratios
Current ratio
0.86
Quick ratio
0.75
Cash ratio
0.23
Cash conversion cycle
86.25
 Solvency ratios
Debt-to-assets ratio
0.49
Debt-to-capital ratio
0.68
Debt-to-equity ratio
2.12
Financial leverage ratio
4.37
Interest coverage
3.17
 Profitability ratios
Gross profit margin
10.15%
Operating profit margin
13.82%
Pretax margin
10.20%
Net profit margin
9.49%
Operating return on assets (Operating ROA)
7.41%
Return on assets (ROA)
5.09%
Return on total capital
11.18%
Return on equity (ROE)
22.22%